Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Lipid-lowering therapy in acute coronary syndrome: Limitations of the stepwise approach and rationale for a 'strike early, strike strong' strategy.
Journal: Current problems in cardiology
Published: May 16, 2026
Targeting BCMA in multiple myeloma with a trifunctional NK cell engager.
Journal: Cell reports. Medicine
Published: August 20, 2025
Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing.
Journal: Journal for immunotherapy of cancer
Published: March 17, 2025
Symptomatic Occlusive Retinal Vasculitis as an Unusual Presentation of Biopsy-Proven Sarcoidosis: A Case Series.
Journal: Ocular immunology and inflammation
Published: February 11, 2025
Comparing diagnostic methods for historical arbovirus outbreaks: Insights from 19th century "dengue" epidemics.
Journal: PLoS neglected tropical diseases
Published: January 08, 2025
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma.
Journal: Science immunology
Published: November 15, 2024
Analysis of 15 cases from a monocentric cohort of 307 liver abscesses.
Journal: Mycoses
Published: June 06, 2023
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123.
Journal: Nature biotechnology
Published: August 10, 2022
Hypervirulent Klebsiella Pneumoniae, an Emerging Cause of Endogenous Endophthalmitis in A French Center: A Comparative Cohort Study.
Journal: Ocular immunology and inflammation
Published: April 12, 2022
Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia.
Journal: Journal of clinical immunology
Published: January 16, 2022
Large retrospective study analysing predictive factors of primary treatment failure, recurrence and death in pyogenic liver abscesses.
Journal: Infection
Published: December 10, 2021
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.
Journal: Open research Europe
Published: October 18, 2021
Last Updated: 09/26/2026